Short-Term High-Dose Psoriasis Therapy Shows Potential for Long-Term Disease Control

(MedPage Today) -- SAN DIEGO -- Short-term, high-dose treatment with risankizumab (Skyrizi) induced long-term control of plaque psoriasis in association with eradication of resident memory T cells (TRM), a small proof-of-principle study showed...

Source: MedPage Today Dermatology - March 13, 2024 Category: Dermatology Source Type: news